Covid-19 vaccine phase 3 testing in July
Los Angeles, June 12 (HS) The Moderna biotech company of Massachusetts announced that after the success of the first two clinical trials, it had finalized plans for phase 3 testing of its Covid-19 vaccine candidate. The trial will include 30,000 participants and was expected to begin in July. The trial will test just one dose level of the vaccine, 100 micrograms, given in two shots.
Similarly, Britain’s Oxford University and AstraZeneca Plc. announced on Thursday that a contract had been signed with Emergent Bio Solutions for vaccine production. Another American company Johnson & Johnson also announced that the company was planning to arrange the final clinical trial in the second week of July.
